Learning Objectives:

1. Define the approved novel therapies for diabetic kidney disease

2. Describe the ways to use these therapies given previous guidance

3. Articulate the possible safety issues with these combined therapies

Session date: 
02/10/2023 - 8:00am to 9:00am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
George Bakris, MD, FASN, FAHA